The antibody treatment bamlanivimab was Lilly’s second-highest selling product in the final quarter of 2020, trailing only the popular diabetes drug Trulicity.
Woodard talked to host Mason King about his adventure restoring the Stutz Business and Arts Center, about his decision to sell a majority share in the complex and what the new owners have in store for the buildings.
Lilly has spent three decades and more than $3 billion trying to find a way to treat Alzheimer’s disease. Its latest drug, donanemab, finally shows real promise.
The school announced the seven-figure gift from Derica Rice and Robin Nelson-Rice on Monday. The donation will support the Kelley School’s Consortium for Graduate Study in Management.
Joshua Smiley, who was Lilly’s second-highest-paid employee, was named CFO in January 2018. Lilly said Smiley also engaged in “inappropriate personal communications” with other employees.
The developer expects demand from workers at large corporate campuses nearby, including those for Eli Lilly and Co., Indiana Farm Bureau and Anthem Inc.
Mayor Andy Cook filed a lawsuit against Cindy Gossard on Jan. 14 to force her to cooperate with examiners performing a city-wide financial investigation and to prohibit her from contracting with a new city payroll vendor.
The vote followed a passionate debate between renewable energy advocates and a group of residents and local officials who said legislation would take away local control.
Josh Smiley, Lilly’s CFO since 2018, resigned from the company after the drugmaker said he had engaged in a improper personal relationship with an employee.
The letter—signed by leaders at Eli Lilly and Co., Elanco, OneAmerica, Anthem Inc., IU Health, Salesforce and Roche Diagnostics, among others—acknowledges that the city faces economic, housing and crime problems, but the executives say they believe local officials are the ones best equipped to tackle those challenges.
A recent pattern of legislative proposals attacks local control in ways that would slow our economic recovery and risk long-term progress on public safety.
If you follow the daily drumbeat of news emanating out of Lilly Corporate Center, you might not grasp how phenomenally well the company is poised to perform in the coming years.
We believe in local control. We expect Republicans to believe in local control, too. And so it’s baffling to us that some of the General Assembly’s most conservative lawmakers are leading the efforts to interfere in the way Indianapolis officials govern their city.
More than 60 business and not-for-profit executives have signed a letter telling lawmakers to back off proposals that would restrict or usurp power from city government in Indianapolis.
The Senate Corrections and Criminal Law Committee on Tuesday amended Senate Bill 168, which would have created a five-member board to oversee and govern the Indianapolis police department, to recommend the issue be discussed in a summer study committee.
Productivity in Indiana’s most advanced industries—including agricultural chemicals, medical equipment and adhesives production—has lagged behind the national average for the past 10 years and the gap is widening, according to a new Brookings Institution study.
The bill pitted the two largest companies headquartered in Indianapolis—drugmaker Eli Lilly and Co. and health insurer Anthem Inc.—on opposite sides of the issue.
Prioritizing access to education and workforce development opportunities is one important and necessary step in the right direction toward a more equitable workforce.
